United States Hydrocephalus Shunts Market Research Report 2022

Market Analysis and Insights: United States Hydrocephalus Shunts Market

Due to the COVID-19 pandemic, the United States Hydrocephalus Shunts market size is estimated to be worth US$ 82.72 million in 2022 and is forecast to a readjusted size of US$ 109.73 million by 2028 with a CAGR of 4.82% during the review period. Fully considering the economic change by this health crisis, Adjustable Valves accounting for 76.37% of the Hydrocephalus Shunts United States market in 2021, is projected to value US$ 87.13 million by 2028, growing at a revised 5.39% CAGR in the post-COVID-19 period. While Adult segment is altered to a 5.18% CAGR throughout this forecast period.

In United States, the key manufacturers of Hydrocephalus Shunts include Medtronic, Integra LifeSciences, B.Braun, SOPHYSA. In 2021, the top three players have a share approximately 95.32% in terms of revenue.

United States Hydrocephalus Shunts Scope and Segment

Hydrocephalus Shunts market is segmented by Type, and by Application. Players, stakeholders, and other participants in the United States Hydrocephalus Shunts market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type, and by Application for the period 2017-2028.

Segment by Type

Adjustable Valves

Monopressure Valves

Segment by Application

Adult

Child

By Company

Medtronic

Integra LifeSciences

B.Braun

SOPHYSA